科微学术

微生物学通报

抗肠道病毒71型的药物研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(81660340);遵义医科大学2018年度学术新苗培育及创新探索专项项目(黔科合平台人才[2018]5772-068);遵义市科技局-遵义医科大学科学技术联合资金项目(遵市科合HZ字[2019]18号;遵市科合HZ字[2020]61号);贵州省教育厅青年科技人才成长项目(黔教合KY[2018]224)


Recent progress towards enterovirus 71 about antiviral agents
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    肠道病毒71型(Enterovirus 71,EV71)是引起重症手足口病(Hand,Foot and Mouth Disease,HFMD)的主要病原体。重症HFMD进展迅速,可表现为严重的神经系统并发症,甚至危及生命。目前临床上防治EV71感染缺乏特异、高效的药物,其残疾率和死亡率很高。随着研究的深入,已经发现了大量具有抗EV71能力的化合物,人们探索的药物机制和药物靶点各不相同。因此,本文从药物靶向病毒、宿主等角度出发,针对抗EV71感染的天然药物、合成药物及常见中药中活性成分作用机制的最新进展进行综述与讨论。此外,对抗病毒药物筛选技术进行简要概述,以期为抗EV71药物的筛选与研发设计等相关研究提供参考。

    Abstract:

    Enterovirus 71 (EV71) belonging to human enterovirus, is the mainly causative agent of severe Hand, Foot and Mouth Disease (HFMD) and has been associated with various neurological complications, even death. There is currently no effective prevention and specific therapy for EV71, following high disability and mortality rates. Along with the profound study, a large number of compounds with anti-EV71 ability have been discovered, and the mechanisms and drug targets explored are different. Thus, from the perspective of drug to virus and host, this paper reviews and discusses the latest progress in the mechanism of active ingredients in natural drugs, synthetic drugs and common traditional Chinese medicine against EV71 infection. In addition, the screening technology of anti-EV71 drugs was briefly summarized, aiming to provide help for the screening, research and development of anti EV71 drugs.

    参考文献
    相似文献
    引证文献
引用本文

乔俊华,孙欣,王盛羽,宋鸿. 抗肠道病毒71型的药物研究进展[J]. 微生物学通报, 2021, 48(12): 4871-4883

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-03-25
  • 最后修改日期:
  • 录用日期:2021-05-25
  • 在线发布日期: 2021-12-03
  • 出版日期:
文章二维码